Business
Press Release Jun 19 2023
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated Jun 19, 2023, titled "Zydus receives final approval from the USFDA for Minocycline Hydrochloride Extended-Release Tablets USP, 55 mg, 65 mg, and 115 mg".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Zydus Lifesciences Limited has informed the Exchange regarding a press release dated Jun 19, 2023, titled \"Zydus receives final approval from the USFDA for Minocycline Hydrochloride Extended-Release Tablets USP, 55 mg, 65 mg, and 115 mg\". View Attachment","length":392,"tagName":"div"}]